Access to anti-retroviral drugs, male in Greece

Greece: Access to anti-retroviral drugs, male was 68.0% in 2024. ▲ Rising

Latest (2024)
68.0%
Change on year
up 1.5%
World rank
73rd
of 141 countries
All-time high
70.0%
in 2017
All-time low
45.0%
in 2005
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Greece, 2000–2024

0204060802000201220242000: 49 %2001: 49 %2002: 49 %2003: 48 %2004: 46 %2005: 45 %2006: 45 %2007: 45 %2008: 46 %2009: 47 %2010: 48 %2011: 50 %2012: 53 %2013: 57 %2014: 60 %2015: 65 %2016: 69 %2017: 70 %2018: 70 %2019: 69 %2020: 68 %2021: 68 %2022: 68 %2023: 67 %2024: 68 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, male in Greece is 68.0%, measured in 2024.

Compared with earlier readings it is up 1.5% on the previous year and up 13.3% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Greece peaked at 70.0% in 2017 and was at its lowest, 45.0%, in 2005.

Greece ranks 73rd of 141 countries on this measure, in the middle of the range.

The long-run direction has been consistently rising across the 25 years of available data.

Access to anti-retroviral drugs, male in Greece, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Greece, 2000 to 2024.
Year % Change
2000 49.0%
2001 49.0% +0.0%
2002 49.0% +0.0%
2003 48.0% -2.0%
2004 46.0% -4.2%
2005 45.0% -2.2%
2006 45.0% +0.0%
2007 45.0% +0.0%
2008 46.0% +2.2%
2009 47.0% +2.2%
2010 48.0% +2.1%
2011 50.0% +4.2%
2012 53.0% +6.0%
2013 57.0% +7.5%
2014 60.0% +5.3%
2015 65.0% +8.3%
2016 69.0% +6.2%
2017 70.0% +1.4%
2018 70.0% +0.0%
2019 69.0% -1.4%
2020 68.0% -1.4%
2021 68.0% +0.0%
2022 68.0% +0.0%
2023 67.0% -1.5%
2024 68.0% +1.5%

Averages by decade

DecadeAverage LowestHighest Years
2000s 46.9% 45.0% 49.0% 10
2010s 61.1% 48.0% 70.0% 10
2020s 67.8% 67.0% 68.0% 5

Countries ranked near Greece

  1. 72 Côte d'Ivoire 69.0% compare
  2. 73 Algeria 68.0% compare
  3. 73 Burkina Faso 68.0% compare
  4. 73 Dominican Republic 68.0% compare
  5. 73 Estonia 68.0% compare

See the full ranking of 160 places →

More gender data for Greece

All data for Greece →

Frequently asked questions

What is access to anti-retroviral drugs, male in Greece?
Access to anti-retroviral drugs, male in Greece was 68.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Greece?
The highest recorded value was 70.0% in 2017.
What is the lowest access to anti-retroviral drugs, male recorded in Greece?
The lowest recorded value was 45.0% in 2005.
How does Greece rank for access to anti-retroviral drugs, male?
Greece ranks 73rd out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Greece?
Over the last ten years it is up 13.3%. The long-run trend across the full record is rising.
Where does this Greece data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Greece. Statizoid, drawing on UNAIDS estimates. Retrieved 08 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/greece/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/greece/">Access to anti-retroviral drugs, male in Greece</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.